Who owns ABIOMED?

Key details on ABIOMED (Ticker: ABMD)

Who owns ABIOMED?

Is ABMD a good stock to own? Find out who bought ABIOMED, who sold ABIOMED (ABMD) stock, and who holds a large position in ABIOMED.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 5.66M $510.72M Dec. 31, 2015
Vanguard 3.05M $276.23M Dec. 31, 2015
Palo Alto Investors 2.89M $260.86M Dec. 31, 2015
BlackRock Fund Advisors 2.63M $237.34M Dec. 31, 2015
Essex Woodlands Health Ventures 2.15M $194.10M Dec. 31, 2015
Jackson Square Partners 1.82M $164.66M Dec. 31, 2015
Tiger Global Management 1.69M $41.96M Sept. 30, 2014
Blue Mountain Capital Management 1.61M $41.87M March 31, 2014
Wellington Management Company 1.31M $93.87M March 31, 2015
Macquarie 1.23M $110.74M Dec. 31, 2015
Next Century Growth Investors 1.17M $29.16M Sept. 30, 2014
Name Goodman & Company, Investment Counsel 1.14M $104.51M Sept. 30, 2015
Millennium Management 1.14M $28.31M Sept. 30, 2014
William Blair $ Company 1.10M $72.28M June 30, 2015
BlackRock Institutional Trust Company, N.A. 1.08M $27.14M June 30, 2014

Who sold ABIOMED?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management March 31, 2011 1.17M $17.02M
Portolan Capital Management March 31, 2011 1.10M $15.92M